Diabetes stocks are surprise winners from Novo Nordisk’s Wegovy study, analysts say By: MarketWatch November 13, 2023 at 12:45 PM EST Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits. Read More >> Related Stocks: DaVita HealthCare Partner Dexcom Inc Insulet Corp Intuitive Surgical Novo Nordisk A/S ADR
